9.
Classification of hypertension related to targeted therapy for RCC
| Severity grading* | Clinical characteristics |
| RCC, renal cell cancer; *, The grading standard adopts the America National Cancer Institute General Terminology Standard for Adverse Events (NCI-CTCAE 4.0); 1 mmHg=0.133 kPa | |
| Grade I | Prehypertension stage (systolic pressure 120−139 mmHg, or diastolic pressure 80−89 mmHg) |
| Grade II | Stage I hypertension (systolic pressure140−1S9 mmHg, or diastolic pressure 90−99 mmHg); Medical intervention is needed. Recurrent or persistent (>24 h) hypertension with symptomatic diastolic pressure increase >20 mmHg, or blood pressure 140/90 mmHg (normal pressure in the past), monotherapy is needed |
| Grade III | Stage II hypertension (systolic pressure ≥160 mmHg, diastolic pressure ≥100 mmHg); multi-drug therapy is needed. |
| Grade IV | Life-threatening hypertension (such as hypertension crisis) requires urgent treatment |
| Grade V | Death |